Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Environmental Toxicology and Pharmacology|July 26, 2011
Dibutyltin exposure decreases granzyme B and perforin in human natural killer cellsReetta Catlin, Hemangini Shah, Arthur D Bankhurst, et al.Oncology (Williston Park, N.Y.)|August 20, 2008
Granulocytic sarcoma in a patient with myelodysplastic syndromeChirag Shah, Srivalli Gopaluni, Juhi Husain, et al.Archives of Toxicology|July 21, 2005
Effects of interleukins 2 and 12 on the levels of granzyme B and perforin and their mRNAs in tributyltin-exposed human natural killer cellsLeeShawn D Thomas, Hemangini Shah, Arthur D Bankhurst, et al.Journal of Neurosurgery. Pediatrics|September 25, 2012
Recurrent meningeal sarcoma successfully treated with stereotactic radiosurgeryMichael Cummings, Varun Chowdhry, Hemangini Shah, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Brain: the common site of relapse in patients with pancoast or superior sulcus tumorsHemangini Shah, Christopher J Anker, Jeffery Bogart, et al.American Journal of Clinical Oncology|December 4, 2004
Primary presentation of glioblastoma multiforme with leptomeningeal metastasis in the absence of previous craniotomy: a case reportSurjeet Pohar, William Taylor, Vishal S Chandan, et al.American Journal of Clinical Pathology|February 26, 2011
Erythrocyte sedimentation rate (ESR) measured by the Streck ESR-Auto Plus is higher than with the Sediplast Westergren method: a validation studyBharathi Vennapusa, Laura De La Cruz, Hemangini Shah, et al.Toxicology|June 24, 2004
Tributyltin exposure causes decreased granzyme B and perforin levels in human natural killer cellsLeeShawn D Thomas, Hemangini Shah, Stephanie A Green, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 5, 2003
Markers of inflammation, proteolysis, and apoptosis in ESRDDominic S C Raj, Hemangini Shah, Vallabh O Shah, et al.Clinical Lung Cancer|June 10, 2005
Dose-intensive thoracic radiation therapy for patients at high risk with early-stage non-small-cell lung cancerJeffrey A Bogart, Tracy E Alpert, Mary C Kilpatrick, et al.Pageof 2